a2 Milk （ASX:A2M) Shares Hit Two-Year High After Guidance Upgrade, Dividend Increase

The a2 Milk Company Ltd (ASX: A2M) rose to a two-year high after the dairy and infant formula group reported strong first-half results, upgraded its FY26 outlook and lifted its interim dividend.

【Stock on the Move】Solstice Minerals (ASX: SLS) Reports Strong Nanadie Copper-Gold Drill Results; Shares Surge 157.14% Last Week

Despite heightened volatility across the Australian share market last week, Western Australia-focused gold and copper-gold explorer Solstice Minerals Limited (ASX: SLS) delivered standout performance after releasing its latest exploration update, with the company’s share price recording a sharp rise over the week.

【异动股】Recce Pharmaceuticals(ASX：RCE)与美国陆军签订战伤护理抗感染研究协议

专注于新一代合成抗感染药物的澳大利亚生物医药企业 Recce Pharmaceuticals Ltd (ASX股票代码：RCE) 宣布与美国陆军外科研究所（USAISR）签署合作研发协议，以评估RECCE 327凝胶在烧伤伤口感染中的应用效果。

TELIX Pharmaceuticals (ASX:TLX) 前列腺癌成像剂新药申请获中国药品监管机构受理

TELIX Pharmaceuticals Ltd (ASX股票代码:TLX)向市场披露，中国药品监管机构已受理其主打药品前列腺癌成像剂TLX591-Px（商品名为Illuccix）的新药申请。

【异动股】Radiopharm Theranostics (ASX:RAD)暴涨61%：脑转移瘤放射性药物诊疗法RAD 101中期试验92%患者达到主要终点

Radiopharm Theranostics Ltd (ASX股票代码:RAD) 在美国开展的RAD 101脑转移瘤2b期临床影像试验中期数据结果积极，引发公司股价周二暴涨逾61%。

【异动股】癌症药预测效果获临床前验证 AI药物发现平台Algorae Pharmaceuticals(ASX:1AI)股价节节飙升

伴随多项积极运营进展的披露，AI赋能制药公司Algorae Pharmaceuticals Ltd (ASX股票代码:1AI) 股价节节攀升，近一月累计上涨超88%。

【异动股】放射性制药公司Cyclopharm (ASX:CYC) 股价大力反弹：Technegas设备在美国商业化部署加速

放射性制药公司Cyclopharm Ltd (ASX股票代码:CYC) 股价异动，周一飙涨22.79%。Cyclopharm基于放射性标记碳的肺部通气成像装置Technegas于2024年7月获得在美国的全额报销资格，目前处于商业化加速阶段。

【异动股】澳洲最大杏仁生产商Select Harvests (ASX:SHV)利润额飙升逾80%

受杏仁价格大幅上涨驱动，澳洲最大的杏仁生产加工企业之一Select Harvests Ltd (ASX股票代码:SHV)实现显著增长。